Prelude Therapeutics, Inc. (PRLD)
5.29
-0.18
(-3.29%)
USD |
NASDAQ |
Aug 31, 12:21
Prelude Therapeutics Gross Profit Margin (Quarterly) : 93.81% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.81% |
| March 31, 2026 | 91.46% |
| December 31, 2025 | 92.59% |
| September 30, 2025 | 93.46% |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 87.78% |
| September 30, 2024 | 86.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 72.58% |
| Twist Bioscience Corp. | 52.76% |
| Beam Therapeutics, Inc. | -1.00K% |
| Revolution Medicines, Inc. | -- |
| Sana Biotechnology, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.20% |
| Return on Assets | -45.82% |
| Return on Invested Capital | -62.25% |
| Profit Margin (Quarterly) | -244.1% |
| Operating Margin (Quarterly) | -270.9% |
| Return on Net Operating Assets | -187.2% |